Stay updated on Pembrolizumab After Weekly Paclitaxel Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab After Weekly Paclitaxel Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab After Weekly Paclitaxel Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:04:30.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed descriptions of a clinical study on pembrolizumab for ovarian cancer and the addition of a statement that all patients will receive treatment. The revision version has also been updated.
    Difference
    48%
    Check dated 2025-04-16T16:53:42.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T11:42:16.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The status of the project has been updated to 'Unknown' and is now verified by University College, London, indicating a significant change in its recruitment status.
    Difference
    0.8%
    Check dated 2025-03-18T13:28:40.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-24T22:46:01.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T15:47:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab After Weekly Paclitaxel Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Weekly Paclitaxel Clinical Trial page.